| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.1M | -3.0% | -4.4% |
| Cost of Revenue | $11.5M | -5.2% | +3.9% |
| Gross Profit | $13.6M | -1.2% | -10.4% |
| R&D Expense | $4.1M | +9.4% | +20.0% |
| SG&A Expense | $5.8M | -10.4% | +2.3% |
| Operating Income | -$2.1M | +30.1% | -96.6% |
| Pre-tax Income | -$2.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.8M | +32.2% | -22.4% |
| Accounts Receivable | $24.4M | -12.0% | +31.7% |
| Current Assets | $46.1M | +3.6% | -0.6% |
| Total Assets | $134.4M | -0.3% | -5.1% |
| Current Liabilities | $54.0M | +1.9% | -9.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.8M | — | — |
| Capital Expenditures | $3.6M | — | — |
| Investing Cash Flow | -$3.7M | — | — |
| Financing Cash Flow | -$2.5M | — | — |
| Free Cash Flow | $1.2M | — | — |
| +27.4% |
| -96.4% |
| Income Tax | -$158K | -283.7% | -149.5% |
| Net Income | -$2.0M | +34.5% | -41.9% |
| EPS (Basic) | -$0.16 | +33.3% | -45.5% |
| EPS (Diluted) | -$0.16 | +33.3% | -45.5% |
| $60.9M |
| +1.0% |
| -11.0% |
| Stockholders' Equity | $73.5M | -1.3% | +0.3% |